Vland Biotech(603739)
Search documents
蔚蓝生物分析师会议-20251105
Dong Jian Yan Bao· 2025-11-05 13:13
蔚蓝生物分析师会议 调研日期:2025年11月05日 调研行业:农牧饲渔 参与调研的机构:投资者网上提问等 / 机构调研pro小程序 DJvanbao.com 洞见研报 出品 : 机构调研pro小程序致力于为金融证券投资者提供最新最全的调研会议纪要。 来机构调研pro小程序,了解最新的:行业投资风向、热门公司关注、权威机构分析... 权威完善的信息持续更新! 更多精彩的机构调报告请移步机构调研pro小程序~ 一解投资机构行业关注度。 频判市场 | Gallia | | | --- | --- | | 11 2 12 200 2 110 | | | 1:给我们 = 影片面临官 = | | | 阿里巴巴佩尼 | | | 钢铁机之题。 8 | 图纸制图: 23 | | 20GB Millio Aller 19 | | | 海双集团 | | | 1 1 80.0 0 | 总机构建 23 | | LOGA: REGH, KETA: 1986 | | | 小麦具日 | | | 的研究次数:8 | 上机构馆:23 | | 定年代的:用者点击:我要的中:主要原因 | | | START SHILL CARD | | | 颜的 ...
蔚蓝生物(603739) - 青岛蔚蓝生物股份有限公司2025年第一次临时股东会会议材料
2025-11-05 08:15
青岛蔚蓝生物股份有限公司 2025 年第一次临时股东会 会议材料 二〇二五年十一月十三日 | 2025 年第一次临时股东会会议议程 1 | | --- | | 2025 年第一次临时股东会会议须知 2 | | 2025 年第一次临时股东会会议议案 3 | | 议案一: 3 | | 关于取消监事会并修订《公司章程》的议案 3 | | 议案二: 49 | | 关于修订、制定公司部分治理制度的议案 49 | 青岛蔚蓝生物股份有限公司 2025 年第一次临时股东会会议议程 一、会议召开的基本情况 (一)会议类型和届次:2025 年第一次临时股东会 (二)会议召开时间、地点: 会议时间:2025 年 11 月 13 日 14 点 30 分 会议地点:青岛市崂山区九水东路 596-1 号蔚蓝生物创新园 B 座多媒体会议 (三)会议出席人员 1、股东、股东代表 2、公司董事、监事和高级管理人员 3、公司聘请的律师 4、其他人员 二、会议议程 (一)报告会议出席情况,宣布会议开始; (二)本次股东会各项议案宣读并审议; (三)股东或股东代表发言及公司董事、监事、高级管理人员回答提问; (四)记名投票表决(由股东、监事及律师组 ...
A股部分流感概念股拉升!华兰疫苗涨18%,沃森生物、特一药业、华兰生物、亨迪药业、万泰生物、百克生物跟涨
Ge Long Hui· 2025-11-04 06:06
(责任编辑:宋政 HN002) 【免责声明】本文仅代表作者本人观点,与和讯网无关。和讯网站对文中陈述、观点判断保持中立,不对所包含内容 的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考,并请自行承担全部责任。邮箱: news_center@staff.hexun.com 格隆汇11月4日|华兰疫苗涨18%,沃森生物(300142)、特一药业(002728)、华兰生物(002007)、蔚蓝生 物(603739)、亨迪药业、万泰生物、百克生物等跟涨。 ...
蔚蓝生物的前世今生:陈刚掌舵打造多元业务格局,酶制剂等业务营收可观,产能布局下的成长新篇
Xin Lang Zheng Quan· 2025-10-31 10:49
Core Insights - The company, Weilan Bio, was established on February 23, 2005, and went public on January 16, 2019, on the Shanghai Stock Exchange, with its registered and office locations in Shandong Province. It is a representative enterprise in the enzyme preparation and probiotic fields in China, with notable advantages in technology research and development [1] Financial Performance - For Q3 2025, Weilan Bio reported a revenue of 1.016 billion yuan, ranking 14th out of 24 in the industry. The top two competitors, Meihua Biological and Xinhengcheng, reported revenues of 18.215 billion yuan and 16.642 billion yuan, respectively, while the industry average was 357.1 million yuan [2] - The net profit for the same period was 82.93 million yuan, placing the company 15th in the industry. The leading competitors reported net profits of 5.354 billion yuan and 3.025 billion yuan, with the industry average at 539 million yuan [2] Financial Ratios - As of Q3 2025, Weilan Bio's debt-to-asset ratio was 37.49%, down from 38.62% year-on-year, which is higher than the industry average of 28.46% [3] - The company's gross profit margin for Q3 2025 was 44.45%, slightly up from 44.18% year-on-year, and also above the industry average of 28.77% [3] Management and Shareholder Information - The chairman and general manager, Chen Gang, received a salary of 1.97 million yuan in 2024, an increase of 499,300 yuan from 2023 [4] - As of September 30, 2025, the number of A-share shareholders decreased by 22.70% to 17,000, while the average number of circulating A-shares held per account increased by 29.36% to 14,900 [5] Strategic Outlook - According to Minsheng Securities, Weilan Bio's revenue and net profit showed fluctuations in the first half of 2025, with Q2 performance improving. The company is focusing on innovation strategies, with significant results in food probiotics and animal health products. The capacity layout is nearing completion, enhancing multi-business synergy [5] - Guoxin Securities noted that the company expects steady revenue growth in 2024 and Q1 2025, with the capacity layout nearly finished. The R&D-driven gross margin for enzyme products is expected to continue rising, benefiting from market expansion due to alternatives to feed antibiotics [5]
化学制品板块10月29日涨1.38%,锦华新材领涨,主力资金净流出8436.35万元
Zheng Xing Xing Ye Ri Bao· 2025-10-29 08:33
Market Overview - The chemical products sector increased by 1.38% on October 29, with JinHua New Materials leading the gains [1] - The Shanghai Composite Index closed at 4016.33, up 0.7%, while the Shenzhen Component Index closed at 13691.38, up 1.95% [1] Top Performers - JinHua New Materials (Code: 920015) closed at 62.92, up 30.00% with a trading volume of 135,600 shares and a turnover of 746 million [1] - WeiLan Bio (Code: 603739) closed at 15.51, up 10.00% with a trading volume of 96,900 shares and a turnover of 148 million [1] - YiNuoWei (Code: 920261) closed at 16.34, up 7.08% with a trading volume of 48,000 shares and a turnover of 75.93 million [1] Underperformers - XianFeng New Materials (Code: 300163) closed at 4.61, down 7.62% with a trading volume of 1,672,400 shares and a turnover of 787 million [2] - JinJi Co., Ltd. (Code: 300798) closed at 7.63, down 5.92% with a trading volume of 230,600 shares and a turnover of 178 million [2] - KaiLi New Materials (Code: 6888889) closed at 41.10, down 5.30% with a trading volume of 40,900 shares and a turnover of 170 million [2] Capital Flow - The chemical products sector experienced a net outflow of 84.36 million from institutional investors, while retail investors saw a net inflow of 87.49 million [2][3] - Major stocks like KaiMeiTeQi (Code: 002549) had a net inflow of 200 million from institutional investors, while DeMeiHuaGong (Code: 002054) saw a net outflow of 155 million [3]
猪周期反转在即?全市场“含猪量”最高农牧渔ETF(159275)强势反攻!机构持续看好
Xin Lang Ji Jin· 2025-10-29 05:23
Group 1 - The agricultural, animal husbandry, and fishery sector experienced a volatile upward trend on October 29, with the highest "pig content" agricultural ETF (159275) reaching a peak intraday increase of 0.81% and closing up 0.51% [1] - Key stocks in the sector included Blue Biological, which hit the daily limit, Meino Biological with over 8% increase, Luoniushan up 6%, and Shennong Seed Industry rising over 5% [1] - The current valuation of the agricultural, animal husbandry, and fishery sector is relatively low, indicating a good time for allocation, with the market's highest "pig content" ETF (159275) having a price-to-book ratio of 2.57, at the 30.08% percentile of the last decade [3] Group 2 - The "anti-involution" measures in the pig industry have been intensified since May, with multiple meetings held by the Ministry of Agriculture, the National Development and Reform Commission, and industry associations to control production capacity and reduce weights [1][4] - It is expected that the pig price will enter a new upward trend in the second half of next year due to accelerated capacity reduction in the fourth quarter [1][4] - The agricultural ETF (159275) tracks the CSI Agricultural, Animal Husbandry, and Fishery Index, with a significant portion (40.25%) of its holdings in the pig farming industry, higher than similar ETFs [8]
青岛蔚蓝生物股份有限公司
Shang Hai Zheng Quan Bao· 2025-10-28 21:46
Group 1 - The adjustment of the value-added tax rate will not affect the company's performance in 2024 and prior years, but it is expected to have an indirect impact on the company's total profit starting in 2025 [1] - The company has implemented measures to mitigate the impact of the tax rate adjustment, including optimizing product pricing and structure, strengthening tax management and cost control, aligning with market demand, and enhancing customer loyalty [1] - The specific financial impact of the tax rate adjustment will be determined by the audit report issued by the accounting firm [1] Group 2 - The company will hold its first extraordinary general meeting of shareholders in 2025 on November 13 at 14:30, located at the Vland Innovation Park in Qingdao [4][5] - Voting for the meeting will be conducted through a combination of on-site and online methods, with specific time slots for online voting [5][6] - Shareholders must register to attend the meeting, with detailed registration methods provided for different types of shareholders [11][12][13]
青岛蔚蓝生物股份有限公司2025年第三季度报告
Shang Hai Zheng Quan Bao· 2025-10-28 21:46
Core Points - The company has announced the cancellation of its supervisory board and the revision of its articles of association, with the responsibilities of the supervisory board being transferred to the audit committee of the board of directors [30][31]. - The company held its 21st meeting of the fifth board of directors on October 28, 2025, where several important resolutions were passed, including the approval of the third quarter report for 2025 [9][10]. - The company plans to hold its first extraordinary general meeting of 2025 on November 13, 2025, to discuss the cancellation of the supervisory board and other governance matters [27]. Financial Data - The third quarter financial report for 2025 has been prepared but is not audited [3][4]. - The report includes significant non-recurring gains and losses, although specific amounts are not detailed in the provided documents [4]. Governance Changes - The company will no longer have a supervisory board, and its functions will be assumed by the audit committee, with necessary amendments made to the articles of association [31]. - Various governance documents and rules are being revised or established to enhance the company's operational standards, including rules for shareholder meetings and board meetings [16][20][21]. Shareholder Information - The company has confirmed that the resolutions passed during the board meeting received unanimous support, with all five directors voting in favor [12][15][28].
蔚蓝生物(603739.SH):第三季度净利润3506.29万元,同比增长205.02%
Ge Long Hui A P P· 2025-10-28 18:17
Core Viewpoint - The company reported a year-on-year increase in revenue and net profit for the third quarter, indicating positive financial performance despite a decline in net profit excluding non-recurring gains [1] Financial Performance - The company achieved operating revenue of 364 million yuan in the third quarter, representing a year-on-year growth of 8.09% [1] - The net profit attributable to shareholders reached 35.06 million yuan, showing a significant year-on-year increase of 205.02% [1] - The net profit attributable to shareholders after deducting non-recurring gains was 6.93 million yuan, reflecting a year-on-year decline of 12.43% [1] - The basic earnings per share were reported at 0.14 yuan [1]
10月28日这些公告有看头
Di Yi Cai Jing· 2025-10-28 14:10
Major Events - *ST Zhengping's stock will be suspended for investigation starting October 29, 2025, due to a significant price increase of 152.42% from September 1 to October 28, 2025, with 21 days of trading halts and 5 instances of abnormal trading fluctuations [2] - Gongjin Co. announced that its major shareholder is planning a share transfer that may lead to a change in control, resulting in the stock being suspended from October 27, 2025, for up to 3 trading days [2] - Jiuquan Technology's wholly-owned subsidiary plans to invest 150 million yuan in establishing an industrial fund focused on chips and integrated circuits [2] Company Announcements - YN Holdings decided to terminate investment in 17 distributed photovoltaic projects originally planned for a total investment of 1.197 billion yuan due to changes in market conditions [3] - Awan New Materials announced a one-day stock suspension on October 29, 2025, due to a tender offer from Shanghai Zhiyuan Hengyue Technology Partnership, aiming to acquire 149,243,840 shares at 7.78 yuan per share [4] - Dahua Intelligent clarified that it currently has no business related to quantum technology despite market speculation [5] Financial Performance - Ganfeng Lithium reported a net profit of 557 million yuan for Q3 2025, a year-on-year increase of 364.02%, with revenues of 6.249 billion yuan, up 44.10% [6] - Light Media's net profit for Q3 2025 reached 1.06 billion yuan, a 993.71% increase, with revenues of 374 million yuan, up 247.54% [6] - Hainan Airport reported a net profit of 64.35 million yuan for the first three quarters of 2025, a decline of 69.77% [7] - Su Li Co. achieved a net profit of 59.42 million yuan in Q3 2025, a 2750% increase, with revenues of 762 million yuan, up 26% [7] - Yutong Bus reported a net profit of 1.357 billion yuan for Q3 2025, a 78.98% increase, with revenues of 10.237 billion yuan, up 32.27% [9] Share Buybacks - Haida Group plans to repurchase shares worth between 1 billion to 1.6 billion yuan for capital reduction and employee stock ownership plans, with a maximum price of 62 yuan per share [20] - Liyuan Information intends to repurchase shares totaling 20 million to 30 million yuan, with a maximum price of 15 yuan per share [21] Major Contracts - Baiao Intelligent won a project worth 97.22 million yuan from a large state-owned company [22] - Guangdong Construction signed a construction contract worth 1.924 billion yuan for a project in Guangzhou, which will enhance its business scale and profitability [22] - Guangqi Technology's subsidiary signed contracts for mass production of metamaterials worth a total of 215 million yuan [23]